ホーム>>Peptides>>Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) (Synonyms: ARTKQTARK-pS-TGGKA, pSer10-Histone H3 (1-15), 1-15 H3pS10, H3S10ph (1-15), H31-15S10ph)

カタログ番号GC43827

ヒストンH3(1-15)(phospho-Ser10)は、人間のヒストンH3配列のアミノ酸残基2〜16に対応するペプチドフラグメントです。

Products are for research use only. Not for human use. We do not sell to patients.

Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
1mg
$170.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Histone H3 (1-15) (phospho-Ser10) is a peptide fragment that corresponds to amino acid residues 2-16 of the human histone H3 sequence. Phosphorylation of histone H3 at serine 10 is correlated with chromatin condensation during mitosis and with transcriptional activation of genes during interphase. Histone H3 (1-15) (phospho-Ser10) does not inhibit binding of the ADD domain of the chromatin-remodeling protein ATRX to histone H3 due to its positioning away from the core peptide binding sequence but does decrease binding of the HP1α chromodomain (CD) when histone H3 is also methylated at lysine 9.

レビュー

Review for Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.